Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy

Membranous nephropathy (MN) is an autoimmune inflammatory disease in which proteins related with plenty of biological processes play an important role. However, the role of these proteins in the pathogenesis of MN is still unclear. This study aimed to screen differential proteins in kidney tissue samples from MN patients by using protein arrays and determine the pathways involved in the pathogenesis of MN. This study first tested a quantitative protein array (QAH-INF-3) and two semiquantitative protein arrays (L-493 and L-507) with normal renal tissue and identified L-493 as the most appropriate assay to compare protein levels between MN tissues and normal control tissues. The L-493 array identified 66 differentially expressed proteins (DEPs) that may be associated with MN. The gene oncology (GO) and protein-protein interaction (PPI) analyses revealed several processes potentially involved in MN, including extracellular matrix disassembly and organization, cell adhesion, cell-cell signaling, cellular protein metabolic process, and immune response (P < 0.05). We suggest that these different pathways work together via protein signaling and result in the pathogenesis and progression of MN.

[1]  Fan Yang,et al.  Effect of matrix metalloproteinase-mediated matrix degradation on glioblastoma cell behavior in 3D PEG-based hydrogels. , 2017, Journal of biomedical materials research. Part A.

[2]  K. Dahan.  [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach]. , 2016, La Revue de medecine interne.

[3]  K. Rajarathnam,et al.  Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions* , 2016, The Journal of Biological Chemistry.

[4]  J. Rendu,et al.  Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency. , 2016, Journal of the American Society of Nephrology : JASN.

[5]  D. Borza.  Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy , 2016, Front. Immunol..

[6]  N. Sheerin,et al.  Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease , 2016, Scientific Reports.

[7]  G. Ghiggeri,et al.  Immunology of membranous nephropathy: from animal models to humans , 2016, Clinical and experimental immunology.

[8]  B. Sutariya,et al.  TGF-β: the connecting link between nephropathy and fibrosis , 2016, Immunopharmacology and immunotoxicology.

[9]  T. Eleftheriadis,et al.  T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome? , 2015, Cytokine.

[10]  Manfè Valentina,et al.  Cytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips , 2015, BMC Biotechnology.

[11]  C. Pusey,et al.  Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression. , 2015, Kidney international.

[12]  T. H. Yeh,et al.  Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  H. Haller,et al.  Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen , 2014, European journal of clinical investigation.

[14]  K. Voskarides,et al.  Molecular genetics of familial hematuric diseases. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  M. L. Alvarez,et al.  Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy , 2013, PloS one.

[16]  N. Câmara,et al.  The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. , 2012, Kidney international.

[17]  J. Ni,et al.  A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy , 2012, PloS one.

[18]  K. Mun,et al.  Effects of cyclosporine on metalloproteinase in endothelial cells. , 2012, Transplantation proceedings.

[19]  M. Kurosaka,et al.  Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration , 2012, Arthritis Research & Therapy.

[20]  Hyun Soon Lee.  Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease , 2011, Cell and Tissue Research.

[21]  Y. Okada,et al.  Absence of Gelatinase (MMP-9) or Collagenase (MMP-13) Attenuates Adriamycin-Induced Albuminuria and Glomerulosclerosis , 2010, Nephron Experimental Nephrology.

[22]  C. Huh,et al.  Evaluation of Anti-colitic Effect of Lactic Acid Bacteria in Mice by cDNA Microarray Analysis , 2009, Inflammation.

[23]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[24]  B. Mayer,et al.  Microarray and Bioinformatics Analysis of Gene Expression in Experimental Membranous Nephropathy , 2009, Nephron Experimental Nephrology.

[25]  E. Wolf,et al.  Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. , 2009, American journal of physiology. Renal physiology.

[26]  L. Thibaudin,et al.  TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. , 2007, Kidney international.

[27]  K. Ivens,et al.  Tumor Necrosis Factor-α Gene G-308A Polymorphism Is a Risk Factor for the Development of Membranous Glomerulonephritis , 2006, American Journal of Nephrology.

[28]  E. Ritz,et al.  Role of calcium-phosphorous disorders in the progression of renal failure. , 2005, Kidney international. Supplement.

[29]  M. Nangaku,et al.  Cellular response to injury in membranous nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[30]  R. Harris,et al.  Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells* , 2004, Journal of Biological Chemistry.

[31]  L. Nasir,et al.  The cloning and functional analysis of canine matrix metalloproteinase-13 gene promoter. , 2002, Gene.

[32]  D. Borza.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[33]  Hyun Soon Lee.  Pathogenic role of TGF-β in the progression of podocyte diseases. , 2011, Histology and histopathology.